Nanovaccinology as Targeted Therapeutics. Группа авторов
Computational, Tribological, Fluorescence, and Influx Study 7.3 Antidiabetic (AD) Study, Anticancer Study, and Anti-Inflammatory Study 7.4 Conclusion References
12 8 Biological, Electronic-Filter, Influx and Theoretical Practicalities of 2-Chloro-6-Nitroaniline (2C6NA) Crystals for Biomedical and Microelectronics Tasks 8.1 Introduction 8.2 Computational and Influx 8.3 Antibacterial, Antifungal, Antidiabetic, DPPH, FRAP, Anticancer 8.4 Conclusion References
13 9 Antidiabetic, Anti-Oxidant, Computational, Filter, and Tribological Characterizations of Bis Glycine Lithium Bromide Monohydrate Nano (32 nm) Scaled Crystals 9.1 Introduction 9.2 Experimental 9.3 Results and Discussions 9.4 Conclusion References
14 10 Device Utility, Energy, and Bioutility of N2MNM4MBH Macro, Nano Models 10.1 Introduction 10.2 Synthesis and XRD 10.3 Influx 10.4 Computational 10.5 Conclusion References
15 11 Biocurative, Tribological, Electro-Functionalities of ZnOMIZN Nanoparticles 11.1 Introduction 11.2 Antibacterial Activity 11.3 XRD and Magnetic Effect 11.4 Tribological Data for Nano Sample Coatings of ZnO-MIZN 11.5 Filter Utility 11.6 Conclusion References
16 12 Nanotubular Device Effect, Super Cell Effectiveness, Hirshfeld Energy Analysis and Biomedicinal Efficacy of 2-Fluoro-5-Nitro-Aniline (2F5NA) Crystals 12.1 Introduction 12.2 XRD and Computational 12.3 Bioutility 12.4 Conclusion References
17 13 Nano, Peptide Link, Pharma Impact and Electron Density of AMPHB Macro, Nano Crystalline Samples 13.1 Introduction 13.2 Characterizations 13.3 Conclusion References
18 14 Super Lattice, Computational Interactions and Bio-Uses of CPDMDP Crystals 14.1 Introduction 14.2 Computational 14.3 Synthesis 14.4 XRD 14.5 Influx of CPDMDP of Both Scales 14.6 Antidiabetic Activity of Macro, Nano CPDMDP Crystals 14.7 Antioxidant Activity 14.8 Conclusion References
19 15 Biological Effect Nanotubular, Vanderwall’s Impact, of 4-Methyl-2-Nitroaniline (4M2NA) Nanocrystals 15.1 Introduction 15.2 XRD and Computational Data 15.3 Biological Activity: Antidiabetic (AD), Anti-Inflammatory (AI), and Antifungal (AF) Effect 15.4 Conclusion, Outlook, and Future Aspects References
20 16 Biomedical, Tribological, and Electronic Functionalities of Silver Nanoparticles 16.1 Introduction 16.2 Tribological Data 16.3 Influx 16.4 HeLa Cell Line, Bacterial and Fungal Utility 16.5 Conclusion References
21
17 Commercialization of Nanovaccines: Utopia or a Reality?
17.1 Introduction
17.2 Development of Nanovaccines
17.3 Novel Adjuvants and Delivery System for Nanovaccines
17.4 Success Story
17.5